Clinical Trials Logo

Clinical Trial Summary

The EMERALD intervention involves 1) ordering an Emergency Department (ED) lipid panel, 2) calculating 10-year Atherosclerotic cardiovascular disease (ASCVD) risk using the Pooled Cohort Equations, 3) prescribing a moderate- or high-intensity statin if applicable, and 4) referring patients to outpatient care (primary care, preventive cardiology, or general cardiology, depending on risk level).


Clinical Trial Description

EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders) is a pilot study seeking to determine the feasibility of initiating medical therapy for hyperlipidemia (HLD) in the Emergency Department (ED) and will collect data essential to inform a future randomized controlled trial comparing ED HLD treatment to usual care. HLD is a key cardiovascular disease (CVD) risk factor that is causally associated with atherosclerotic cardiovascular disease (ASCVD), the leading cause of US mortality and morbidity. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05742841
Study type Interventional
Source Wake Forest University Health Sciences
Contact
Status Completed
Phase Phase 4
Start date March 8, 2023
Completion date July 15, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05095688 - Relationship Between Adipose Tissue Distribution and Arterial Stiffness in HFpEF
Recruiting NCT06015620 - Comorbidities Resolution After MGB Surgery and Change in Body Composition
Enrolling by invitation NCT05645367 - Associations of Lipid Measures With Premature Myocardial Infarction: a Cross-sectional Study
Recruiting NCT05611307 - Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
Active, not recruiting NCT05637866 - SRMA of the Effect of Soy Milk vs Cow's Milk on Cardiometabolic Outcomes
Completed NCT05276271 - The Effect of Levetiracetam on Lipid Profile in Children
Recruiting NCT05514938 - Polypill in Acute Coronary Syndrome Phase 2
Recruiting NCT02009345 - Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada
Completed NCT04641494 - The Effect of CLA on Obesity, Lung Functions, Lipid Profile and Inflammation in Women With BMI≥25 N/A
Active, not recruiting NCT05598216 - Assessment of Different Equations to Accurately Calculate LDL Cholesterol
Recruiting NCT05107869 - Effect of Plasma Ceramides on Peripheral Vascular Function N/A
Recruiting NCT05195164 - The Effects of Orchiectomy and Age on Vascular and Metabolic Health in Older Versus Younger Transgender Women
Completed NCT03027570 - The Impact of Incorporating an Exergame Activity Application in a Treatment Regimen for Overweight Children N/A
Recruiting NCT06276205 - Vitamin D & Levothyroxine Combination Versus Levothyroxine on Lipid Profile in Hypothyroidism Phase 3
Completed NCT03544411 - Effects of Olive Oil and Bran Oil on Antioxidant Levels, Glycemic Control, and Lipid Profile in Patient Type 2 DM Phase 1
Recruiting NCT04237467 - Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Men
Recruiting NCT02305862 - A High-Resolution Magnetic Resonance Imaging Study to Evaluate the Effect of Rosuvastatin on Carotid Atherosclerotic Plaques N/A
Not yet recruiting NCT00277121 - Genetic Origin of Lipid Disorders Phase 1
Completed NCT03885661 - Vascepa to Accelerate Lipoprotein Uptake and Elimination Phase 1
Enrolling by invitation NCT05398393 - An Experimental Study on the Effect of Tenofovir Amibufenamide on Blood Lipid During Anti-HBV Treatment N/A